Sigyn Therapeutics (SIGY) Shares Outstanding (2016 - 2025)

Sigyn Therapeutics has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $1.6 million in Q3 2025.

• Quarterly Shares Outstanding (Entity) rose 13.0% year-over-year to $1.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.6 million (up 13.0% YoY) and the FY2024 annual result came in at $1.3 million, up 3.42% from the prior year.
• Shares Outstanding (Entity) held at $1.6 million in Q3 2025 per SIGY's latest filing, from $1.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $44.2 million in Q3 2023 and troughed at $1.2 million in Q1 2024.
• A 5-year average of $23.1 million and a median of $36.6 million in 2021 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) jumped 5649.49% in 2021, then slumped 97.14% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $37.3 million in 2021, then increased by 2.6% to $38.3 million in 2022, then sank by 96.63% to $1.3 million in 2023, then climbed by 3.42% to $1.3 million in 2024, then rose by 20.48% to $1.6 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.